SNSE
Sensei Biotherapeutics, Inc.
Key Financials
Operating Income
$-22288000
↑ 31.7%
Net Income
$-21085000
↑ 30.1%
Total Assets
$22.9M
↓ 49.5%
EPS (Diluted)
$-16.72
↓ 1293.3%
Shareholders' Equity
$18.6M
↓ 51.6%
Total Liabilities
$4.3M
↓ 38.2%
Cash & Equivalents
$8.7M
↓ 13.3%
Operating Cash Flow
$-20453000.00
↑ 17.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/16/2026 | View on SEC |
| PRE 14A | 4/16/2026 | View on SEC |
| 8-K/A | 4/15/2026 | View on SEC |
| 4 | 4/14/2026 | View on SEC |
| 4 | 4/14/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| D | 3/4/2026 | View on SEC |
| SCHEDULE 13G | 2/25/2026 | View on SEC |
| 144 | 2/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SNSE |
| Company Name | Sensei Biotherapeutics, Inc. |
| CIK | 1829802 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (240) 243-8000 |